

Stellar Biotechnologies caters to the essential molecule demands of pharmaceutical and immunodiagnostic markets. Among its major competitors, Stellar Biotechnologies is ranked in 5th place for NPS while Biogen is 1st, and Athersys is 2nd.Their current market cap is $5.60M